Bio Developments

Australian government awards funding to Indee Labs for microfluidic chip development

04-Sep-2018 By Maggie Lynch

NSW Medical Device Fund awarded Indee Labs funding for the company’s preclinical trial with their microfluidic chip alongside University of Sydney.

Q&A

Testa Center will help GE better serve bioprocessing industry, says CEO

03-Sep-2018 By Flora Southey

GE Nordics CEO Lotta Ljungqvist says the recently opened Testa Center will help facilitate innovation in the biopharmaceutical space.

AZ’s potential Lupus treatment hits rocks in trial

31-Aug-2018 By Ben Hargreaves

AstraZeneca has revealed that a Phase III trial investigating its mAb treatment for Lupus came back with negative results.

NIH funds consortium to establish center for biomedical modeling

31-Aug-2018 By Maggie Lynch

The National Institute of Health (NIH) awarded $6.5m to a consortium of universities to create the Center for Reproducible Biomedical Modeling.

Novartis further invests in cell and gene therapy manufacture, after Kymriah approval

29-Aug-2018 By Ben Hargreaves

Novartis plans to step up its capabilities of manufacturing cell and gene therapies with a new facility to be built in Stein, Switzerland.

CAR-T comes to Europe: Novartis and Gilead receive EU approvals

28-Aug-2018 By Ben Hargreaves

In a landmark decision, the European Commission has approved both Novartis’ Kymriah and Gilead’s Yescarta for the treatment of patients within the EU.

Ebola vaccinations to return in DR Congo following outbreak

24-Aug-2018 By Maggie Lynch

Vaccinations against Ebola will be administered in the Democratic Republic of Congo following a recently declared outbreak.

GE Healthcare opens bioprocessing ‘test bed’ for biotechs

21-Aug-2018 By Flora Southey

The Testa BioProcess Innovation Center in Sweden will help academics, startups, and biopharmaceutical companies secure industrial proof-of-concepts quicker, and with less cost, says GE Healthcare.

Pfizer signs $425m mRNA flu vaccine agreement with BioNTech

20-Aug-2018 By Maggie Lynch

BioNTech signed a collaboration agreement with Pfizer to conduct joint research on a mRNA-based flu vaccine.

Samsung looks to expand CDMO biz with $22bn investment

17-Aug-2018 By Flora Southey

Samsung plans to invest KRW 180 trillion into its various businesses over the next three years, including in biomanufacturing-focused Samsung BioLogics.

Japanese scientists conduct first clinical trial for Parkinson’s using iPS cells

17-Aug-2018 By Maggie Lynch

Japanese scientists at Kyoto University were granted government permission to begin clinical trials using reprogrammed adult stem cells.

LenioBio and Fraunhofer Institute to develop protein expression platform

15-Aug-2018 By Maggie Lynch

LenioBio and Fraunhofer Institute IME have entered a licensing agreement, allowing LenioBio to commercialize technology into a protein expression platform.